M. Schuiveling

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma

K. Suijkerbuijk, R. Verheijden, E. Tonk, 2020, Cancer Immunology, Immunotherapy.

Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?

T. Radstake, N. Vazirpanah, J. Broen, 2017, Current drug targets.

mTOR inhibition by metformin impacts monosodium urate crystal–induced inflammation and cell death in gout: a prelude to a new add-on therapy?

T. Merriman, T. Radstake, A. Phipps-Green, 2019, Annals of the rheumatic diseases.